[Medullotherapy in hematopoietic depression].
Many-year observations, made by the authors, indicated that the main mechanism of medullotherapy is healing of histocompatible allogenic bone marrow, transplanted against the background of immunosuppressive therapy. In patients with hyperplastic anemia bone marrow transplantation results in a persistant clinico-hematologic remission. Observations, made by the workers of the Leningrad Institute of Hematology and Blood Transfusion, have demonstrated that transplantations of the preserved autologous bone marrow to patients with malignant neoplasms contribute to the restoration of hemopoiesis, suppressed by high doses of chemical drugs and associated radiotherapy.
D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D010051:Ovarian Neoplasms / Q000628:therapy; D013852:Thiotepa / Q000008:administration & dosage; D013997:Time Factors; D014182:Transplantation, Autologous; D014594:Uterine Neoplasms / Q000628:therapy
D003520:Cyclophosphamide; D013852:Thiotepa
O medulloterapii pri depressii krovetvoreniia.